<code id='8FE8069128'></code><style id='8FE8069128'></style>
    • <acronym id='8FE8069128'></acronym>
      <center id='8FE8069128'><center id='8FE8069128'><tfoot id='8FE8069128'></tfoot></center><abbr id='8FE8069128'><dir id='8FE8069128'><tfoot id='8FE8069128'></tfoot><noframes id='8FE8069128'>

    • <optgroup id='8FE8069128'><strike id='8FE8069128'><sup id='8FE8069128'></sup></strike><code id='8FE8069128'></code></optgroup>
        1. <b id='8FE8069128'><label id='8FE8069128'><select id='8FE8069128'><dt id='8FE8069128'><span id='8FE8069128'></span></dt></select></label></b><u id='8FE8069128'></u>
          <i id='8FE8069128'><strike id='8FE8069128'><tt id='8FE8069128'><pre id='8FE8069128'></pre></tt></strike></i>

          hotspot

          hotspot

          author:explore    Page View:1463
          Photography of the US department of health and human services in Silver Spring MD
          Manuel Balce Ceneta/AP

          An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

          Triple-check your data or we’ll reject your device, the FDA warned.

          advertisement

          The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          Biogen joins immunology wave with $1.15 billion acquisition of HI
          Biogen joins immunology wave with $1.15 billion acquisition of HI

          RubyWallauforSTATBiogenisjoiningtheindustry’sfervoroverimmuneandinflammatorydiseasedrugdevelopmentwi

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          UnitedHealth argues against case alleging wrongful AI care denials

          AdobeUnitedHealthGroupshouldbereleasedfromalawsuitthatallegesitsalgorithm-basedtechnologyprematurely